SODIUM BICARBONATE
BICARBONATES·METABOLIC ACIDOSIS·+5
LONG GROVE PHAR
Indication
Toxic phenobarbital serum level
A toxic phenobarbital serum level is a laboratory-defined clinical state of barbiturate overdose where circulating concentrations of phenobarbital exceed the standard therapeutic range, typically surpassing 40 mcg/mL. Read more about Toxic phenobarbital serum level
25 drugs 21 manufacturers
Drugs that treat it
Common Toxic phenobarbital serum level therapies.
SODIUM BICARBONATE
BICARBONATES·METABOLIC ACIDOSIS·+5
OMNIVIUM PHARMA
SODIUM BICARBONATE
BICARBONATES·METABOLIC ACIDOSIS·+5
Hospira
SODIUM BICARBONATE
BICARBONATES·METABOLIC ACIDOSIS·+5
GLENMARK PHARMA
SODIUM BICARBONATE
BICARBONATES·METABOLIC ACIDOSIS·+5
REMEDYREPACK, I
SODIUM BICARBONATE
BICARBONATES·METABOLIC ACIDOSIS·+5
EXELA PHARMA SC
SODIUM BICARBONATE
BICARBONATES·METABOLIC ACIDOSIS·+5
MILLA PHARMACEU
Filter & compare in the drug finder →Opens the drug finder with Toxic phenobarbital serum level preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA toxic phenobarbital serum level is a laboratory-defined clinical state of barbiturate overdose where circulating concentrations of phenobarbital exceed the standard therapeutic range, typically surpassing 40 mcg/mL.
This condition primarily affects the central nervous and cardiovascular systems across pediatric and adult populations receiving therapy or experiencing accidental or intentional ingestion.
Pathophysiologically, excessive serum levels hyperactivate gamma-aminobutyric acid type A receptors, inducing generalized central nervous system depression that clinically manifests as lethargy, ataxia, nystagmus, hypothermia, progressive coma, respiratory depression, and life-threatening circulatory collapse.
- umaryland.edu
A toxic phenobarbital serum level is a laboratory-defined clinical state of barbiturate overdose where circulating concentrations of phenobarbital exceed the standard therapeutic range, typically surpassing 40 mcg/mL
- nih.gov
Pathophysiologically, excessive serum levels hyperactivate gamma-aminobutyric acid type A receptors, inducing generalized central nervous system depression that clinically manifests as lethargy, ataxia, nystagmus, hypothermia, progressive coma, respiratory depression, and life-threatening circulatory collapse
- nih.gov
Pathophysiologically, excessive serum levels hyperactivate gamma-aminobutyric acid type A receptors, inducing generalized central nervous system depression that clinically manifests as lethargy, ataxia, nystagmus, hypothermia, progressive coma, respiratory depression, and life-threatening circulatory collapse
- nih.gov
Pathophysiologically, excessive serum levels hyperactivate gamma-aminobutyric acid type A receptors, inducing generalized central nervous system depression that clinically manifests as lethargy, ataxia, nystagmus, hypothermia, progressive coma, respiratory depression, and life-threatening circulatory collapse
Personalize your experience
Follow Toxic phenobarbital serum level and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.